1. Home
  2. Clinical Topics
  3. FDA approves seasonal flu vaccine made using novel technology
Clinical TopicsDrugs and DevicesHealthcare & TechnologyInfection PreventionNewsWeb Exclusives

FDA approves seasonal flu vaccine made using novel technology

Share

On Jan. 16, 2012, the U.S. Food and Drug Administration (FDA) approved Flublok, the first trivalent influenza vaccine made using an insect virus (baculovirus) expression system and recombinant DNA technology. This new technology may enable a faster start-up of vaccine manufacturing should a pandemic occur. Flubok is approved for people 18 through 49 years of age. Read more.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts